JOIN A CLINICAL RESEARCH STUDY
Diagnosed with Schizophrenia in the past 5 years?
You may be eligible
Join Now
Currently recruiting adults with early-phase schizophrenia for a 24-week clinical research study evaluating an FDA-approved treatment option.
Schizophrenia is a mental health condition that can affect how a person thinks, feels, and interacts with others. Early symptoms may include hearing or seeing things others do not, confusion, withdrawal from family or friends, difficulty concentrating, changes in mood or behavior, or unusual thoughts and beliefs. Early evaluation and treatment may help improve daily functioning and quality of life.
Who Can Participate?
This study is for adults who have been diagnosed with schizophrenia within the last 5 year. In addition to the criteria listed, participants must meet the following requirements:
- Are 18 - 40 years of age
- Currently taking one stable antipsychotic medication
- currently receiving outpatient care
Each clinical study has its own guidelines for who can participate, called eligibility criteria. There are other requirements for participation in this study. However, only the research study staff can determine if you qualify to enroll in the study.
What to Expect?
If this study may be a fit for you, you’ll be invited to a screening visit at our facility in Richmond,
TX.
All of the study procedures will be clearly explained to you during screening and can be found in the
informed
consent document (ICD). You may request a copy of the ICD prior to your scheduled screening if you would
like
additional time to review.
Disease
SchizophreniaAge Requirement
18 - 40 YearsTotal Visits
up to 13 visitsDuration
Approximately 24 WeeksSite Location
Richmond, TXCompensation
Up to $900 upon study completionInterested in participating?
Thank you for your interest in learning more about our clinical research opportunities. Complete and submit this form, and our Patient Enrollment Specialist(PES) team will contact you.
You may also call 281-916-4220 and speak with a representative to learn more.